Cue Biopharma
Price & Volume
Stats
See more52W Range | $4.97-$45.50 |
Market Cap | $233.4M |
Shares Short | 349,876 |
Financials
See moreRevenue (12 Mos) | $32.7M |
Revenue Growth (YoY) | 1,250.6% |
Gross Profit (12 Mos) | -$862,000 |
Diluted EPS | -$29.46 |
News
See moreYahoo Finance • last month
Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
Yahoo Finance • last month
Cue Biopharma to raise $50M in oversubscribed private placement
Yahoo Finance • last month
Cue Biopharma Announces $50.0 Million Private Placement
Yahoo Finance • 2 months ago
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
About
CEO | Dr. Shao-Lee Lin M.D., Ph.D. |
Address | 40 Guest Street, Boston, MA, United States, 02135 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 29 |